Last reviewed · How we verify
Perioperative hypertension
Approved treatments
- Nitroglycerin · Fougera
Nitroglycerin forms nitric oxide, activating guanylate cyclase and increasing cyclic GMP, leading to smooth muscle relaxation and vasodilation. - Brevibloc In Plastic Container · Pfizer
Brevibloc works by blocking the beta-1 adrenergic receptor, which reduces the heart's response to stress and increases heart rate. - Brevibloc · AOP Orphan Pharmaceuticals AG
- nitroglycerine · University Hospital, Ghent
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Perioperative hypertension patent landscape — cliff calendar, originator estates, attackable patents
- Perioperative hypertension treatment landscape brief
- Perioperative hypertension treatment updates RSS
Frequently asked questions about Perioperative hypertension
What drugs treat Perioperative hypertension?
Tracked treatments include Nitroglycerin, Brevibloc In Plastic Container, Brevibloc, nitroglycerine.
What is the treatment for Perioperative hypertension?
Standard treatment for Perioperative hypertension includes Nitroglycerin, Brevibloc In Plastic Container, Brevibloc, nitroglycerine. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Perioperative hypertension patent cliff · Perioperative hypertension CI report
- Treatment: Nitroglycerin · Fougera
- Treatment: Brevibloc In Plastic Container · Pfizer
- Treatment: Brevibloc · AOP Orphan Pharmaceuticals AG
- Treatment: nitroglycerine · University Hospital, Ghent
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing